PSI Opens New Italian Office
News Aug 29, 2013
PSI CRO has announced opening of a new operational office in Italy. The Italian office further expands PSI’s well-established presence in Europe and strengthens PSI’s ability to deliver global clinical trials.
The PSI CRO Italy S.r.l. office is located just outside Milan at Via Badia n.55, 20060 Gessate. It will give PSI the location and support to continue attracting and recruiting top talent in the industry.
PSI has been placing clinical trials in Italy for a number of years on behalf of pharmaceutical and biotech sponsors.
They have gained extensive knowledge and experience with local investigative sites in the areas of oncology, haematology, haemophilia, acute care, infectious diseases, CNS, diabetes, and other therapeutic areas.
A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.READ MORE